Cargando…
The Susceptibility of Trypanosomatid Pathogens to PI3/mTOR Kinase Inhibitors Affords a New Opportunity for Drug Repurposing
BACKGROUND: Target repurposing utilizes knowledge of “druggable” targets obtained in one organism and exploits this information to pursue new potential drug targets in other organisms. Here we describe such studies to evaluate whether inhibitors targeting the kinase domain of the mammalian Target of...
Autores principales: | Diaz-Gonzalez, Rosario, Kuhlmann, F. Matthew, Galan-Rodriguez, Cristina, da Silva, Luciana Madeira, Saldivia, Manuel, Karver, Caitlin E., Rodriguez, Ana, Beverley, Stephen M., Navarro, Miguel, Pollastri, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160303/ https://www.ncbi.nlm.nih.gov/pubmed/21886855 http://dx.doi.org/10.1371/journal.pntd.0001297 |
Ejemplares similares
-
Anilinoquinoline based inhibitors of trypanosomatid proliferation
por: Ferrins, Lori, et al.
Publicado: (2018) -
Kinases
as Druggable Targets in Trypanosomatid Protozoan
Parasites
por: Merritt, Christopher, et al.
Publicado: (2014) -
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases
por: Santucci, Matteo, et al.
Publicado: (2021) -
Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma
por: Benavides-Serrato, Angelica, et al.
Publicado: (2020) -
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus
por: Silic-Benussi, Micol, et al.
Publicado: (2023)